Detail of the clinical trial

Title of the trial International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
EudraCT number 2017-000705-20
Protocol number EsPhALL2017/COGAALL1631
Sponsor UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA, Piazza dell´ Ateneo Nuovo 1, 20126 Milano, Italy
Indications Hemato-oncology
Diagnosis lymphoblastic leukemia
Population in clinical trial Infants and Toddlers (28 days - 23 months)
Children (2-11 years)
Adolescents (12-17 years)
Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 26.9.2018
Date of approval by EC 20.6.2018
Date of initiation CT in ČR 7.11.2018
Date of ending CT in ČR
Notice
Sites



























(discontinued)
(discontinued)
(discontinued)
Fakultní nemocnice v Motole, Klinika dětské hematologie a onkologie, V Úvalu 84, 150 06 Praha 5

‹‹ Back to list